Impact of Dark Triad Personality Traits on COVID-19 Vaccination Uptake and Prevention Efforts: Insights from the European Covid Survey (ECOS) DOI Creative Commons

Sophia Bock,

Sebastian Neumann‐Böhme, Petra Steinorth

et al.

Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown

Published: Dec. 25, 2023

Abstract Background: Even though the COVID-19 vaccination roll-out in general can be considered as one of most successful public health campaigns history medicine, hesitancy has remained an issue concern throughout world. We add to a deeper understanding by identifying what drives primary and booster uptake, well adherence simple preventive measures such physical distancing investigating role Dark Triad personality traits, i.e. Machiavellianism, narcissism, psychopathy. Methods: investigate data from Germany United Kingdom European Covid Survey which was collected 23 December 2021 10 January 2022. Logit regressions random effects were performed study effect dark traits on COVID-19-related prevention. Results: show that have substantial impact prevention efforts, vaccinations uptake against COVID-19. Specifically, individuals scoring high psychopathy significantly less likely received immunization. The difference amounts 10.5%-points. High narcissistic imply substantially higher likelihood (15.3%-points) refuse shots after having vaccinations. Therefore, may constitute special case demand for vaccines. In addition, with psychopathic tendencies engage other behavior, while scores narcissism lead reported measures. Conclusions: Our findings highlight crucial plays pandemic related Policymakers, professionals, those charge messaging take these factors into account when devising communication strategies improve behaviors. Future pandemics crises would benefit targeted, nuanced approaches promote greater health.

Language: Английский

Digital Health Reimbursement Strategies of 8 European Countries and Israel: Scoping Review and Policy Mapping DOI Creative Commons
Robin van Kessel, Divya Srivastava, Ilias Kyriopoulos

et al.

JMIR mhealth and uhealth, Journal Year: 2023, Volume and Issue: 11, P. e49003 - e49003

Published: Sept. 29, 2023

Background The adoption of digital health care within systems is determined by various factors, including pricing and reimbursement. reimbursement landscape for in Europe remains underresearched. Although emergency decisions were made during the COVID-19 pandemic to enable delivery through videoconferencing asynchronous (eg, apps), research so far has primarily focused on policy innovations that facilitated this outside Europe. Objective This study examines strategies 8 European countries (Belgium, France, Germany, Italy, Netherlands, Poland, Sweden, United Kingdom) Israel. Methods We mapped available using a scoping review mapping framework. reviewed literature MEDLINE, Embase, Global Health, Web Science databases. Supplementary records identified Google Scholar country experts. Results Our search strategy yielded total 1559 records, which 40 (2.57%) ultimately included study. As August 2023, solutions are reimbursable some extent all studied except although mechanism differs significantly across countries. At time writing, was mostly discussions between national or regional committees manufacturers absence value-based assessment mechanisms. Financing traditional schemes possible Poland typically occurs via innovation health–specific funding schemes. have frameworks range from nonexistent embryonic. Conclusions Studied show divergent approaches solutions. These differences may complicate ability patients seek cross-country another country, even if app both Furthermore, fragmented environment will present challenges developers such solutions, as they look expand their impact systems. An increased emphasis developing clear conceptualization health, well mechanisms, needed sustainable integration health. can therein serve basis further, more detailed field evolves.

Language: Английский

Citations

36

Categorising interventions to enhance vaccine uptake or reduce vaccine hesitancy in the United Kingdom: A systematic review and meta-analysis DOI Creative Commons
Aysegul Humeyra Kafadar, Serena Sabatini, Katy A. Jones

et al.

Vaccine, Journal Year: 2024, Volume and Issue: 42(25), P. 126092 - 126092

Published: July 2, 2024

Vaccination is one of the most important public health interventions to combat infectious disease. However, vaccine hesitancy prevents us reaching global target uptake (e.g., 75 % influenza vaccination in at-risk groups). This review summarises all designed reduce and increase for types vaccines offered adults (≥18 years) since 2000, United Kingdom (UK). PubMed, Cochrane Reviews, CINAHL EBSCO, Scopus were searched (September 19, 2023). The PRISMA Checklist 2020 was used quality checking. Data from randomised-controlled trials (RCTs) analysed with a meta-analysis narrative analysis. In included studies, synthesis undertaken summarise, evaluate characterise reported behaviour change into four categories: organisational-level, demand, provider-level, multidimensional interventions. Findings are evaluated based on MINDSPACE framework understand possible psychological mechanisms underpinning A total 9,842 articles identified, 50 met inclusion criteria. Interventions aimed boost or (50 %), COVID-19 (32 hepatitis B (6 other vaccines. conducted nine RCTs evaluating various impact uptake. pooled effect statistically significant (OR 95 CI = 1.23 [1.07 1.41]). Providing certain understandable information using reminder system personal messages letters frequently documented effective enhance demand (enhance salience). Organisational level intended make vaccinations more accessible providing at alternative places times). Provider-oriented encouraged healthcare workers focus reducing enhancing Among main techniques, salience priming by improving access identified as applied UK.

Language: Английский

Citations

4

Impact of Dark Triad personality traits on COVID-19 vaccination uptake and prevention efforts: insights from the European Covid Survey (ECOS) DOI Creative Commons

Sophia Bock,

Sebastian Neumann‐Böhme, Petra Steinorth

et al.

BMC Public Health, Journal Year: 2025, Volume and Issue: 25(1)

Published: April 10, 2025

Abstract Background Even though the COVID-19 vaccination roll-out in general can be considered as one of most successful public health campaigns history medicine, hesitancy has remained an issue concern throughout world. We add to a deeper understanding by identifying what drives primary and booster uptake, well adherence simple preventive measures such physical distancing investigating role Dark Triad personality traits, i.e. Machiavellianism, narcissism, psychopathy. Methods investigate data from Germany United Kingdom European Covid Survey which was collected 23 December 2021 10 January 2022. Logit regressions random effects were performed study effect dark traits on COVID-19-related prevention. Results find statistically significant association between prevention efforts, vaccinations, uptake against COVID-19. Specifically, individuals scoring high psychopathy are associated with lower likelihood having received immunization. The marginal amounts 3.31%-points. High narcissistic correlated substantially higher (4.52%-points) refuse shots after vaccinations. may relevant factors vaccine-related decision-making. In addition, psychopathic tendencies report significantly engagement other behavior, while scores narcissism reported measures. Conclusions Our findings highlight crucial that plays pandemic-related Policymakers, professionals, those charge messaging take these into account when devising communication strategies improve behaviors. Future pandemics crises would benefit targeted, nuanced approaches promote greater health.

Language: Английский

Citations

0

Internet use and physical and mental health in old age during the COVID-19 pandemic: Evidence from partners in SHARE DOI
Gianmaria Niccodemi, Alessandra Gaia, Noemi Novello

et al.

Economics & Human Biology, Journal Year: 2025, Volume and Issue: unknown, P. 101487 - 101487

Published: April 1, 2025

Language: Английский

Citations

0

Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries DOI Creative Commons
Iryna Sabat, Sebastian Neumann‐Böhme, Pedro Pita Barros

et al.

Vaccine, Journal Year: 2023, Volume and Issue: 41(36), P. 5304 - 5312

Published: July 16, 2023

This paper investigates the prevalence and determinants of three main states people's willingness to be vaccinated (WTBV) against COVID-19 - willing, unwilling hesitant occurrence predictors shifts between these over time. Understanding dynamics vaccine intentions is crucial for developing targeted campaigns increase uptake emergency response preparedness.A panel survey consisting 9 quarterly waves data collected April 2020 January 2022. Baseline included 24 952 adults from Germany, UK, Denmark, Netherlands, France, Portugal, Italy recruited online panels construct census-matched nationally representative samples.Self-reported intention was outcome. Multinomial logit random effects models were used analyze relationships interest. All results reported as relative risk ratios (RRR).Hesitancy get most unstable intention, with on average 42% ever respondents remaining in this state through future waves, followed by 'unwilling' (53%) 'willing (82%). Following news, trust information government, GPs WHO, preferences, perceptions, confidence vaccines (or lack thereof) predicted vaccination reversals. Risk preferences acted both an impediment a facilitator depending initial intention.This study revealed dynamic nature its 7 European countries. The findings provide insights policymakers designing more effective communication strategies, particularly at vaccinate population groups, public health emergencies.

Language: Английский

Citations

10

Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries DOI Creative Commons

Wanzhen Xie,

Leiyu Shi,

Meiheng Liu

et al.

International Journal for Equity in Health, Journal Year: 2024, Volume and Issue: 23(1)

Published: Jan. 30, 2024

Abstract Objective The aim of this study was to examine the Coronavirus disease 2019(COVID-19) vaccine policies disparities and effectiveness in Germany, Denmark Bulgaria, with a view providing lessons for global vaccination response possible outbreak risks. Methods This analyzed big data through public information on official websites Ministries Health European Union, Bulgaria World Organization. We systematically summarized COVID-19 three countries, selected following six indicators cross-cutting comparisons: doses administered per 100 people, rate, share people fully vaccinated, only partly cumulative confirmed cases million, deaths million. Meanwhile, we four measuring policy implementation: daily effective reproduction rate (Rt), moving-average case fatality (CFR). Results Although these EU countries had same start time vaccination, supply coordinated by EU, there are still differences priorities, types, appointment methods. Compared Germany Denmark, least efficient efforts worst coverage, just over 30% as June 2023, maximum million since began country more than times that other two countries. From perspective implementation effect, has certain effect reducing infection death but spread new mutant strains obviously aggravates severity epidemic reduces vaccine. Among them, Omicron strain most serious impact showing an obvious peak. Conclusions Expanding coverage played positive role mortality rates stabilizing Rt. Priority strategies targeting older at-risk groups have been shown be population. However, emergence variant strains, relaxation prevention policies, led multiple outbreaks peaking. In addition, hesitancy, mistrust government ill-prepared health systems hampering efforts. notable ones divergent types responses safety issue could fuel hesitancy around vaccination. At stage, it is also necessary continue include priority plans promote booster prevent severe illness death. Improving fairness distribution degree focus future work.

Language: Английский

Citations

2

Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa? DOI Creative Commons
Obinna Ositadimma Oleribe, Andrew W. Taylor‐Robinson,

Okey Nwanyanwu

et al.

Risk Management and Healthcare Policy, Journal Year: 2024, Volume and Issue: Volume 17, P. 505 - 511

Published: March 1, 2024

Four years after the first case of COVID-19, world is still determining how best to prevent and control long-term effects SARS-CoV-2 infection.Non-pharmaceutical interventions (NPIs) were employed at start pandemic as only available options, prior effective vaccines antiviral agents.The World Health Organization recommended dual vaccination for 70% worldwide threshold a return "normal" community life.Immunization rates needed increase in all global regions, irrespective socioeconomic status, necessitating more equitable access.During pandemic, wealthier countries hoarded vaccine supplies even when their citizens immunized.This highlights already enormous difficulties healthcare provision faced by low-income sub-Saharan African countries, which remain risk industrialized nations have progressed post-pandemic era.Thus, addition redoubling efforts public health policymakers should consider ongoing future use NPIs.In this narrative account, we advocate that various NPI practices not be shelved; rather, research evaluate impact parallel with booster vaccination.This especially applies so-called "long COVID".Lessons learned from implementing resource-limited settings incorporated into preparedness guidelines infectious disease outbreaks.

Language: Английский

Citations

2

Management of vaccinations in patients with non‐Hodgkin lymphoma DOI Creative Commons
Michele Merli, Andrea Costantini, Silvio Tafuri

et al.

British Journal of Haematology, Journal Year: 2024, Volume and Issue: 204(5), P. 1617 - 1634

Published: March 26, 2024

Summary Vaccinations are fundamental tools in preventing infectious diseases, especially immunocompromised patients like those affected by non‐Hodgkin lymphomas (NHLs). The COVID‐19 pandemic made clinicians increasingly aware of the importance vaccinations potential life‐threatening SARS‐CoV‐2‐related complications NHL patients. However, several studies have confirmed a significant reduction vaccine‐induced immune responses after anti‐CD20 monoclonal antibody treatment, thus underscoring need for refined immunization strategies In this review, we summarize existing data about and other vaccine's efficacy with propose multidisciplinary team‐based recommendations management vaccines specific group

Language: Английский

Citations

2

Changes in digital healthcare search behavior during the early months of the COVID-19 pandemic: A study of six English-speaking countries DOI Creative Commons
Robin van Kessel, Ilias Kyriopoulos, Alicja Mastylak

et al.

PLOS Digital Health, Journal Year: 2023, Volume and Issue: 2(5), P. e0000241 - e0000241

Published: May 1, 2023

Public interest is an important component influencing the likelihood of successfully implementing digital healthcare. The onset COVID-19 pandemic allowed us to assess how public in health changed response disruptions traditional services. In this study, we used a difference-in-differences approach determine healthcare search behavior shifted during early months compared same period 2019 across six English-speaking countries: United States, Canada, Kingdom, New Zealand, Australia, and Ireland. most cases, observed that official declaration on 11 March 2020 was associated with significant overall increase volume searches. We also found notable heterogeneity between countries terms keywords were for healthcare, which could be explained by linguistic differences or different national landscapes. Since online searches initial step pathway accessing services, future studies should investigate under what circumstances increased translates into demand utilization

Language: Английский

Citations

5

Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022 DOI Creative Commons
Eftychia Kotronia, Magdalena Rosińska, Małgorzata Stępień

et al.

Frontiers in Public Health, Journal Year: 2023, Volume and Issue: 11

Published: Dec. 4, 2023

Despite the availability, safety and effectiveness of COVID-19 vaccines, Poland remains one six countries European Union with lowest cumulative uptake vaccine's primary course in general population. This study examined willingness to vaccinate associated factors samples unvaccinated vaccinated adults between March 2021 April 2022. Data were collected using OBSER-CO, a nationwide, repeated cross-sectional study, conducted at four different time points (rounds). on among (at all rounds) receive another dose 2 rounds-after booster introduction), reasons for reluctance, sociodemographic, health, behavioral uniform questionnaire via computer-assisted telephone interviewing. In each round, more than 20,000 respondents interviewed. To assess associations vaccinate, separate multivariable logistic regression models fitted factor round adjusted confounders. Between rounds 1 4 (March 2021-April 2022), unvaccinated, declined from 73 12%, whereas vaccinated, 90 53%. The highest magnitude decline subsequent occurred during Omicron wave. Overall, concerns about side effects, effectiveness, vaccine adverse effects common but decreased over time. Age, gender, employment, place residence, diagnosis or exposure, hospitalization, participation social activities willingness. However, changed highlighting influence pandemic waves variants. We observed declining multifactorial Poland, attitudes dynamically changing across rounds. address concerns, sustained health communication vaccines is essential, especially after emergence new

Language: Английский

Citations

2